Literature DB >> 20979972

Hypovitaminosis D, neighborhood poverty, and progression of chronic kidney disease in disadvantaged populations.

R Mehrotra1, K Norris.   

Abstract

In the United States, there are significant racial disparities in the incidence and prevalence of end-stage renal disease. The disparities are greatest for the Blacks and the magnitude of disparity is significantly greater than is evident from the incidence and prevalence data of end-stage renal disease - early stage chronic kidney disease is less common in Blacks and during that stage, mortality rate is significantly higher for that racial group. Recent studies have identified a genetic predisposition for non-diabetic renal disease among Blacks. However, genetic factors explain only part of the higher risk and the racial disparities are a result of a complex interplay of biology and sociology. Herein we focus on two factors and their role in explaining the higher risk for progression of chronic kidney disease among Blacks - one biologic (vitamin D deficiency) and one sociologic (neighborhood poverty). A greater Understanding of these factors is important in order to reduce the racial disparities in the United States.

Entities:  

Mesh:

Year:  2010        PMID: 20979972      PMCID: PMC3191381     

Source DB:  PubMed          Journal:  Clin Nephrol        ISSN: 0301-0430            Impact factor:   0.975


  21 in total

Review 1.  Potential role of active vitamin D in retarding the progression of chronic kidney disease.

Authors:  Jin Tian; Youhua Liu; Laura A Williams; Dick de Zeeuw
Journal:  Nephrol Dial Transplant       Date:  2006-11-22       Impact factor: 5.992

2.  Neighborhood poverty and racial differences in ESRD incidence.

Authors:  Nataliya Volkova; William McClellan; Mitchel Klein; Dana Flanders; David Kleinbaum; J Michael Soucie; Rodney Presley
Journal:  J Am Soc Nephrol       Date:  2007-12-05       Impact factor: 10.121

Review 3.  Vitamin D deficiency.

Authors:  Michael F Holick
Journal:  N Engl J Med       Date:  2007-07-19       Impact factor: 91.245

4.  Racial differences in mortality among those with CKD.

Authors:  Rajnish Mehrotra; Dulcie Kermah; Linda Fried; Sharon Adler; Keith Norris
Journal:  J Am Soc Nephrol       Date:  2008-04-02       Impact factor: 10.121

5.  Antiproteinuric effect of oral paricalcitol in chronic kidney disease.

Authors:  Rajiv Agarwal; Muralidhar Acharya; Jin Tian; Richard L Hippensteel; Joel Z Melnick; Ping Qiu; Laura Williams; Daniel Batlle
Journal:  Kidney Int       Date:  2005-12       Impact factor: 10.612

6.  The prevalence of hypovitaminosis D among US adults: data from the NHANES III.

Authors:  Ashraf Zadshir; Naureen Tareen; Deyu Pan; Keith Norris; David Martins
Journal:  Ethn Dis       Date:  2005       Impact factor: 1.847

7.  Vitamin D status in Andhra Pradesh : a population based study.

Authors:  C V Harinarayan; T Ramalakshmi; U V Prasad; D Sudhakar
Journal:  Indian J Med Res       Date:  2008-03       Impact factor: 2.375

8.  Hypovitaminosis D in chronic kidney disease.

Authors:  Rajnish Mehrotra; Dulcie Kermah; Matthew Budoff; Isidro B Salusky; Sang Shaou Mao; Yan Lin Gao; Junichiro Takasu; Sharon Adler; Keith Norris
Journal:  Clin J Am Soc Nephrol       Date:  2008-04-16       Impact factor: 8.237

9.  Oral calcitriol for the treatment of persistent proteinuria in immunoglobulin A nephropathy: an uncontrolled trial.

Authors:  Cheuk-Chun Szeto; Kai-Ming Chow; Bonnie Ching-Ha Kwan; Kwok-Yi Chung; Chi-Bon Leung; Philip Kam-Tao Li
Journal:  Am J Kidney Dis       Date:  2008-04-03       Impact factor: 8.860

10.  Socioeconomic status and the incidence of ESRD.

Authors:  Michael M Ward
Journal:  Am J Kidney Dis       Date:  2008-02-07       Impact factor: 8.860

View more
  2 in total

1.  Chronic kidney disease identification in a high-risk urban population: does automated eGFR reporting make a difference?

Authors:  Laura C Plantinga; Delphine S Tuot; Vanessa Grubbs; Chi-yuan Hsu; Neil R Powe
Journal:  J Urban Health       Date:  2012-12       Impact factor: 3.671

2.  Prescribed Renoprotective Chinese Herbal Medicines Were Associated with a Lower Risk of All-Cause and Disease-Specific Mortality among Patients with Chronic Kidney Disease: A Population-Based Follow-Up Study in Taiwan.

Authors:  Chuan-Fa Hsieh; Huan-Cheng Chang; Song-Lih Huang; Chien-Lung Chen; Wei-Ta Chen; Chen-Chang Yang
Journal:  Evid Based Complement Alternat Med       Date:  2017-07-17       Impact factor: 2.629

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.